Temasek-based investment firm SeaTown Holdings International announced Wednesday its investment via SeaTown Private Capital Master Fund (SeaTown PCap Fund) in AddVita, a Singapore headquartered healthcare and life sciences distribution company.

With a capital commitment of up to S$115 million ($89.09 million) from SeaTown PCap Fund, this investment positions AddVita as an enduring home for small and medium-sized healthcare and life sciences distribution businesses across Asia, providing them with a strong foundation and network to accelerate their growth, SeaTown said in a statement.

AddVita aims to become Asia’s most trusted and impactful healthcare and life sciences distribution network.

By building a strong ecosystem of empowered small and medium-sized businesses, the firm aspires to create a healthier future and transform healthcare accessibility and quality through a steadfast focus on innovation and collaboration.

The firm will look to acquire market-leading niche businesses in Asia, specialising in distributing highquality medical, laboratory and pharmaceutical products and services.

Backed by SeaTown PCap Fund’s capital support and strategic guidance, AddVita will continue to grow by executing a “Buyand-Build” strategy centered on its long-term vision.

Through these targeted investments and strategic partnerships, AddVita will establish a platform of high-quality products and services that improve access to and quality of healthcare across Asia.

SeaTown PCap Fund’s investment also reflects its confidence in AddVita’s vision and aligns with SeaTown’s long-term private equity strategy, which focuses on a buy-and-build approach emphasizing scalable growth and value creation.

With over a decade of private equity experience in Asia and more than $400 million committed into buy-and-build investment opportunities, SeaTown said it is well-positioned to support AddVita’s growth.

“We are excited to support AddVita in its mission to empower small and medium-sized businesses, enhancing healthcare access and quality across Asia,

“The healthcare distribution sector is resilient, with robust secular growth tailwinds,” said Dickson Loo, Managing Director of Private Equity at SeaTown.

“Our high-quality partners have also demonstrated the ability to generate strong cash flow and sustainable earnings growth. With SeaTown’s partnership, we are confident that AddVita will emerge as a leader in the region’s healthcare distribution sector, unlocking significant value creation opportunities,” he added.

Founded and headquartered in Singapore since 2009, SeaTown is a Asia-focused alternative investment firm with deep expertise across private and public markets.

Owned by Seviora Holdings, Temasek’s asset management group, the firm is investing alongside its investors in conviction-driven strategies.

The firm’s alternative investment fund platform offers international investors exposure to highly specialized private equity, private credit, and thematic public equity opportunities in the region.

AddVita offers an enduring home for small and medium-sized businesses in Asia that distribute medical, laboratory and pharmaceutical products and services.

The firm focuses on acquiring and developing market-leading niche businesses with strong cash flow and sustainable earnings growth.


#HealthcareInvestment #LifeSciences #PrivateEquity #BuyAndBuild #AsiaHealthcare